Breaking News Instant updates and real-time market news.

LITE

Lumentum

$57.25

-1.25 (-2.14%)

, AAPL

Apple

$160.86

-0.64 (-0.40%)

08:28
09/13/17
09/13
08:28
09/13/17
08:28

3D Sensing applications 'front and center' at Apple launch, says Stifel

Stifel analyst Patrick Newton noted that VCSEL enabled applications were "front and center" during Apple's (AAPL) iPhone X launch event. While there was no explicit mention that there are two VCSEL arrays in the front-facing camera, he remains confident this is the case, adding that the later than expected November 3 shipment date should not materially impact Lumentum's ability to meet its target of over $200M in VCSEL orders in 2017. Newton, who continues to model 80% share for Lumentum's in the initial VCSEL ramp, keeps a Buy rating on the stock.

LITE

Lumentum

$57.25

-1.25 (-2.14%)

AAPL

Apple

$160.86

-0.64 (-0.40%)

  • 25

    Sep

  • 26

    Sep

LITE Lumentum
$57.25

-1.25 (-2.14%)

08/31/17
RSBL
08/31/17
NO CHANGE
RSBL
Lumentum may have won exclusive supply deal with Apple, says Rosenblatt
08/31/17
RSBL
08/31/17
NO CHANGE
RSBL
Lumentum checks indicate exclusive supply deal with Apple, says Rosenblatt
Rosenblatt's research indicates Apple (AAPL) has signed an exclusive supply deal with Lumentum (LITE) on VCSEL laser supply for DOE/WLO structure light solutions.. In the firm's view, Lumentum's VCSEL+DOE structure forms a unique pattern, which would be exclusive for Apple's 3D sensing and help Lumentum maintain a large share at Apple in 2018.
09/05/17
STFL
09/05/17
NO CHANGE
Target $30
STFL
Buy
Finisar estimates lowered following peer commentary at Stifel
Stifel analyst Patrick Newton has lowered his FY18 and FY19 estimates for Finisar (FNSR) and is now modeling one more step down in China following recent commentary from competitors such as Lumentum (LITE), Oclaro (OCLR) and MACOM (MTSI) indicating that China is expected to decline again sequentially in the September quarter. Based on the reduced expectations, he lowered his price target on Finisar shares to $30 from $33, but he maintains a Buy rating on the stock.
09/13/17
PIPR
09/13/17
NO CHANGE
Target $68
PIPR
Overweight
Piper reiterates Overweight on Lumentum after Apple unveils 3D sensing
Piper Jaffray analyst Troy Jensen reiterates an Overweight rating on Lumentum Holdings (LITE) with a $68 price target after Apple (AAPL) unveiled 3D sensing in its latest iPhone. Lumentum offers the best way to play the 3D sensing market and the company's time-to-market advantage with Apple will result in ongoing design wins with other smart phone manufacturers, Jensen tells investors in a research note. He believes Lumentum has continued to receive volume production orders since reporting $200M in 3D sensing bookings in the June quarter.
AAPL Apple
$160.86

-0.64 (-0.40%)

09/13/17
STFL
09/13/17
NO CHANGE
STFL
Apple reveal positive for Cirrus Logic, Power Integrations, says Stifel
Stifel analyst Tore Svanberg doesn't believe there were many surprises from Apple's (AAPL) product reveal event, though he notes there had been a lot of speculation around the digital audio interface dongle being excluded. However, Apple's website shows it is still included "in-box" for all three iPhone models, removing near-term risk of content loss for Cirrus Logic (CRUS), he said. He also sees the event as positive for Power Integrations (POWI), which he views as the best-positioned power management IC company to capitalize on Fast Charger adoption, Svanberg tells investors. He keeps Buy ratings on Cirrus and Power Integrations.
09/13/17
OPCO
09/13/17
NO CHANGE
OPCO
Perform
Apple most unexpected feature was custom-designed GPU, says Oppenheimer
Oppenheimer analyst Andrew Uerkwitz says the leaks in recent months substantially reduced the excitement over Apple's newly announced products. The analyst notes that most of iPhone X's features were widely reported before, and the most unexpected feature was Apple's custom-designed GPU. While the company proves again that it stands on the bleeding edge of mobile processor design, smartphone AR, and image capturing, Uerkwitz believes new iPhones are unlikely to fundamentally change the current competitive dynamics of the smartphone market. He reiterates a Perform rating on the shares.
09/13/17
RBCM
09/13/17
NO CHANGE
RBCM
Apple new iPhone features will cause demand to accelerate, says RBC Capital
RBC Capital analyst Amit Daryanani says that the new form factor and capabilities of Apple's new iPhones will cause upgrades within the Apple install base to accelerate and increase the rate of switching to iPhone from other devices. The analyst expects the current iPhone cycle to be "one of the strongest in recent years." He keeps a $180 price target and an Outperform rating on the shares.
09/13/17
STFL
09/13/17
NO CHANGE
Target $6
STFL
Hold
New Apple Watch will be 'stiff competition' for Fitbit Ionic, says Stifel
Stifel analyst Jim Duffy pointed to some advantages favoring Fitbit's (FIT) Ionic over Apple's (AAPL) Watch Series 3 - such as compatibility with non-iOS devices, longer battery life and a narrow price advantage - but he also thinks the Series 3 will present "stiff competition for consumer attention" during the Holidays. He keeps a Hold rating and $6 price target on Fitbit on the heels of Apple's launch event yesterday.

TODAY'S FREE FLY STORIES

ENB

Enbridge

$39.39

-0.33 (-0.83%)

, SEP

Spectra Energy Partners

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Hot Stocks
Enbridge, Spectra Energy Partners complete elimination of IDRs »

Enbridge (ENB) and…

ENB

Enbridge

$39.39

-0.33 (-0.83%)

SEP

Spectra Energy Partners

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

OMER

Omeros

$16.70

-0.02 (-0.12%)

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Hot Stocks
Omeros receives positive opinion for OMS721 from EMA »

Omeros Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIX

Edison International

$62.12

0.2 (0.32%)

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Recommendations
Edison International analyst commentary  »

Edison International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWOU

2U

$72.38

1.49 (2.10%)

07:09
01/22/18
01/22
07:09
01/22/18
07:09
Hot Stocks
2U and WeWork partner in online graduate program expansion »

2U and WeWork Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NQ

NQ Mobile

$3.82

-0.07 (-1.80%)

07:07
01/22/18
01/22
07:07
01/22/18
07:07
Hot Stocks
NQ Mobile proposes to rebrand, change name to "Link Motion Inc." »

NQ Mobile announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

bluebird bio

$175.95

-6.15 (-3.38%)

07:07
01/22/18
01/22
07:07
01/22/18
07:07
Technical Analysis
Technical Take: bluebird bio moves higher »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

OPB

Opus Bank

$28.70

0.05 (0.17%)

07:07
01/22/18
01/22
07:07
01/22/18
07:07
Earnings
Opus Bank reports Q4 EPS including items 3c, consensus 38c »

Reports net income of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CQH

Cheniere Energy Partners LP

$28.22

0.22 (0.79%)

, CQP

Cheniere Energy Partners

$30.48

0.2 (0.66%)

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Conference/Events
Morgan Stanley to hold a tour »

Annual Morgan Stanley…

CQH

Cheniere Energy Partners LP

$28.22

0.22 (0.79%)

CQP

Cheniere Energy Partners

$30.48

0.2 (0.66%)

ENLC

EnLink Midstream

$18.75

0.25 (1.35%)

ENLK

EnLink Midstream Partners

$17.45

0.37 (2.17%)

EPD

Enterprise Products

$28.66

0.36 (1.27%)

NBLX

Noble Midstream

$55.10

-0.48 (-0.86%)

PAA

Plains All American

$22.49

-0.09 (-0.40%)

SHLX

Shell Midstream

$30.13

-0.03 (-0.10%)

TRGP

Targa Resources

$50.73

0.04 (0.08%)

WES

Western Gas Partners

$52.31

0.34 (0.65%)

WGP

Western Gas Equity

$40.42

0.5 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 07

    Feb

  • 16

    Feb

  • 20

    Feb

REGN

Regeneron

$371.53

0.25 (0.07%)

, SNY

Sanofi

$44.60

0.09 (0.20%)

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Hot Stocks
Regeneron reports approval of Dupixent in Japan for atopic dermatitis »

Regeneron (REGN)…

REGN

Regeneron

$371.53

0.25 (0.07%)

SNY

Sanofi

$44.60

0.09 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 02

    May

SLB

Schlumberger

$76.42

0.05 (0.07%)

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTNP

Titan Pharmaceuticals

$1.28

0.025 (2.00%)

, BBRX

Braeburn Pharmaceuticals

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Hot Stocks
Titan Pharmaceuticals discussing U.S. Probuphine commercialization with Braeburn »

Titan Pharmaceuticals…

TTNP

Titan Pharmaceuticals

$1.28

0.025 (2.00%)

BBRX

Braeburn Pharmaceuticals

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$54.02

2.42 (4.69%)

, MMM

3M

$248.18

2.27 (0.92%)

07:05
01/22/18
01/22
07:05
01/22/18
07:05
Conference/Events
ASHRAE and AHRI to co-host an expo »

The American Society of…

CC

Chemours

$54.02

2.42 (4.69%)

MMM

3M

$248.18

2.27 (0.92%)

ABB

ABB

$28.01

0.03 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 15

    Feb

07:05
01/22/18
01/22
07:05
01/22/18
07:05
General news
Oil Action: WTI benchmark futures are fractionally lower »

Oil Action: WTI benchmark…

ACBFF

Aurora Cannabis

$10.77

0.302 (2.89%)

07:05
01/22/18
01/22
07:05
01/22/18
07:05
Hot Stocks
CanniMed announces continuation of discussions with Aurora Cannabis »

CanniMed Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$17.33

0.12 (0.70%)

07:04
01/22/18
01/22
07:04
01/22/18
07:04
Hot Stocks
Athenex announces results of first cohort of Phase 1b clinical trial of Oraxol »

Athenex announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEVB

Level Brands

$5.10

-0.0385 (-0.75%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
Level Brands, Kathy Ireland announce extension of Isodiol license agreement »

Kathy Ireland, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABAX

Abaxis

$61.16

0.35 (0.58%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
Abaxis granted USDA Approval for new VetScan FLEX4 Rapid Test »

Abaxis' new VetScan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

QURE

uniQure

$17.99

-0.01 (-0.06%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
uniQure receives OMPD in EU for AMT-130 »

uniQure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTX

BioTime

$2.64

-0.02 (-0.75%)

07:02
01/22/18
01/22
07:02
01/22/18
07:02
Hot Stocks
BioTime sees submitting Renevia for CE mark during Q1 »

BioTime expects to submit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCN

Neovasc

$0.55

0.0313 (6.02%)

07:02
01/22/18
01/22
07:02
01/22/18
07:02
Hot Stocks
Neovasc CEO Alexei Marko to depart, Fred Colen to succeed »

Neovasc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$57.75

-2.25 (-3.75%)

, VIA

Viacom

$39.20

-0.5 (-1.26%)

07:01
01/22/18
01/22
07:01
01/22/18
07:01
Downgrade
CBS, Viacom, Viacom rating change  »

CBS downgraded on higher…

CBS

CBS

$57.75

-2.25 (-3.75%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

AER

AerCap

$54.11

0.38 (0.71%)

07:01
01/22/18
01/22
07:01
01/22/18
07:01
Hot Stocks
AerCap leased, purchased and sold 402 aircraft in 2017 »

AerCap Holdings has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

07:01
01/22/18
01/22
07:01
01/22/18
07:01
Hot Stocks
Bristol-Myers Yervoy expanded indication approved by EC »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

LRCX

Lam Research

$207.53

2.08 (1.01%)

, TSM

TSMC

$44.67

0.1 (0.22%)

07:00
01/22/18
01/22
07:00
01/22/18
07:00
Recommendations
Lam Research, TSMC, Ichor Holdings analyst commentary  »

Lam Research price target…

LRCX

Lam Research

$207.53

2.08 (1.01%)

TSM

TSMC

$44.67

0.1 (0.22%)

ICHR

Ichor Holdings

$32.39

-0.36 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 07

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

07:00
01/22/18
01/22
07:00
01/22/18
07:00
Recommendations
Apple analyst commentary  »

Wells Fargo maintains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.